According to this study, Global Melanoma Drugs market size will reach US$ 5909 million by 2031.

Global Melanoma Drugs Market Size and Outlook 2025-31

According to this study, the global Melanoma Drugs market size will reach US$ 5909 million by 2031. Melanoma drugs are medications used to treat melanoma, a type of skin cancer. They include targeted therapies, immunotherapies, and chemotherapy drugs. The market for melanoma drugs is driven by the rising incidence of melanoma and the demand for effective and personalized cancer treatments. The markets growth is also influenced by ongoing research in melanoma therapeutics, leading to the development of novel drugs and combination therapies. LPI (LP Information) newest research report, the Melanoma Drugs Industry Forecast looks at past sales and reviews total world Melanoma Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Melanoma Drugs sales for 2025 through 2031. With Melanoma Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Melanoma Drugs industry. This Insight Report provides a comprehensive analysis of the global Melanoma Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Melanoma Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Melanoma Drugs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Melanoma Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Melanoma Drugs. This report presents a comprehensive overview, market shares, and growth opportunities of Melanoma Drugs market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Chemotherapy &nbsp;&nbsp;&nbsp; Immunotherapy &nbsp;&nbsp;&nbsp; Targeted Therapy Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospitals &nbsp;&nbsp;&nbsp; Clinics &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Amgen &nbsp;&nbsp;&nbsp; Bristol-Myers Squibb &nbsp;&nbsp;&nbsp; Roche &nbsp;&nbsp;&nbsp; Genentech &nbsp;&nbsp;&nbsp; Janssen Biotech &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; Takeda Pharma &nbsp;&nbsp;&nbsp; Teva Pharma &nbsp;&nbsp;&nbsp; Merck Group &nbsp;&nbsp;&nbsp; Shanghai Junshi Biosciences Co.,Ltd &nbsp;&nbsp;&nbsp; Innovent Biologics &nbsp;&nbsp;&nbsp; Jiangsu Hengrui Medicine Co.,Ltd. &nbsp;&nbsp;&nbsp; BeiGene, Ltd. &nbsp;&nbsp;&nbsp; Grand Pharmaceutical (China) Co., Ltd

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Melanoma Drugs Market Size (2020-2031) &nbsp;2.1.2 Melanoma Drugs Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Melanoma Drugs by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Melanoma Drugs Segment by Type &nbsp;2.2.1 Chemotherapy &nbsp;2.2.2 Immunotherapy &nbsp;2.2.3 Targeted Therapy &nbsp;2.3 Melanoma Drugs Market Size by Type &nbsp;2.3.1 Melanoma Drugs Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Melanoma Drugs Market Size Market Share by Type (2020-2025) &nbsp;2.4 Melanoma Drugs Segment by Application &nbsp;2.4.1 Hospitals &nbsp;2.4.2 Clinics &nbsp;2.4.3 Others &nbsp;2.5 Melanoma Drugs Market Size by Application &nbsp;2.5.1 Melanoma Drugs Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Melanoma Drugs Market Size Market Share by Application (2020-2025) 3 Melanoma Drugs Market Size by Player &nbsp;3.1 Melanoma Drugs Market Size Market Share by Player &nbsp;3.1.1 Global Melanoma Drugs Revenue by Player (2020-2025) &nbsp;3.1.2 Global Melanoma Drugs Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Melanoma Drugs Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Melanoma Drugs by Region &nbsp;4.1 Melanoma Drugs Market Size by Region (2020-2025) &nbsp;4.2 Global Melanoma Drugs Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Melanoma Drugs Market Size Growth (2020-2025) &nbsp;4.4 APAC Melanoma Drugs Market Size Growth (2020-2025) &nbsp;4.5 Europe Melanoma Drugs Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Melanoma Drugs Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Melanoma Drugs Market Size by Country (2020-2025) &nbsp;5.2 Americas Melanoma Drugs Market Size by Type (2020-2025) &nbsp;5.3 Americas Melanoma Drugs Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Melanoma Drugs Market Size by Region (2020-2025) &nbsp;6.2 APAC Melanoma Drugs Market Size by Type (2020-2025) &nbsp;6.3 APAC Melanoma Drugs Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Melanoma Drugs Market Size by Country (2020-2025) &nbsp;7.2 Europe Melanoma Drugs Market Size by Type (2020-2025) &nbsp;7.3 Europe Melanoma Drugs Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Melanoma Drugs by Region (2020-2025) &nbsp;8.2 Middle East & Africa Melanoma Drugs Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Melanoma Drugs Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Melanoma Drugs Market Forecast &nbsp;10.1 Global Melanoma Drugs Forecast by Region (2026-2031) &nbsp;10.1.1 Global Melanoma Drugs Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Melanoma Drugs Forecast &nbsp;10.1.3 APAC Melanoma Drugs Forecast &nbsp;10.1.4 Europe Melanoma Drugs Forecast &nbsp;10.1.5 Middle East & Africa Melanoma Drugs Forecast &nbsp;10.2 Americas Melanoma Drugs Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Melanoma Drugs Forecast &nbsp;10.2.2 Canada Market Melanoma Drugs Forecast &nbsp;10.2.3 Mexico Market Melanoma Drugs Forecast &nbsp;10.2.4 Brazil Market Melanoma Drugs Forecast &nbsp;10.3 APAC Melanoma Drugs Forecast by Region (2026-2031) &nbsp;10.3.1 China Melanoma Drugs Market Forecast &nbsp;10.3.2 Japan Market Melanoma Drugs Forecast &nbsp;10.3.3 Korea Market Melanoma Drugs Forecast &nbsp;10.3.4 Southeast Asia Market Melanoma Drugs Forecast &nbsp;10.3.5 India Market Melanoma Drugs Forecast &nbsp;10.3.6 Australia Market Melanoma Drugs Forecast &nbsp;10.4 Europe Melanoma Drugs Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Melanoma Drugs Forecast &nbsp;10.4.2 France Market Melanoma Drugs Forecast &nbsp;10.4.3 UK Market Melanoma Drugs Forecast &nbsp;10.4.4 Italy Market Melanoma Drugs Forecast &nbsp;10.4.5 Russia Market Melanoma Drugs Forecast &nbsp;10.5 Middle East & Africa Melanoma Drugs Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Melanoma Drugs Forecast &nbsp;10.5.2 South Africa Market Melanoma Drugs Forecast &nbsp;10.5.3 Israel Market Melanoma Drugs Forecast &nbsp;10.5.4 Turkey Market Melanoma Drugs Forecast &nbsp;10.6 Global Melanoma Drugs Forecast by Type (2026-2031) &nbsp;10.7 Global Melanoma Drugs Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Melanoma Drugs Forecast 11 Key Players Analysis &nbsp;11.1 Amgen &nbsp;11.1.1 Amgen Company Information &nbsp;11.1.2 Amgen Melanoma Drugs Product Offered &nbsp;11.1.3 Amgen Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Amgen Main Business Overview &nbsp;11.1.5 Amgen Latest Developments &nbsp;11.2 Bristol-Myers Squibb &nbsp;11.2.1 Bristol-Myers Squibb Company Information &nbsp;11.2.2 Bristol-Myers Squibb Melanoma Drugs Product Offered &nbsp;11.2.3 Bristol-Myers Squibb Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Bristol-Myers Squibb Main Business Overview &nbsp;11.2.5 Bristol-Myers Squibb Latest Developments &nbsp;11.3 Roche &nbsp;11.3.1 Roche Company Information &nbsp;11.3.2 Roche Melanoma Drugs Product Offered &nbsp;11.3.3 Roche Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Roche Main Business Overview &nbsp;11.3.5 Roche Latest Developments &nbsp;11.4 Genentech &nbsp;11.4.1 Genentech Company Information &nbsp;11.4.2 Genentech Melanoma Drugs Product Offered &nbsp;11.4.3 Genentech Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Genentech Main Business Overview &nbsp;11.4.5 Genentech Latest Developments &nbsp;11.5 Janssen Biotech &nbsp;11.5.1 Janssen Biotech Company Information &nbsp;11.5.2 Janssen Biotech Melanoma Drugs Product Offered &nbsp;11.5.3 Janssen Biotech Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Janssen Biotech Main Business Overview &nbsp;11.5.5 Janssen Biotech Latest Developments &nbsp;11.6 Novartis &nbsp;11.6.1 Novartis Company Information &nbsp;11.6.2 Novartis Melanoma Drugs Product Offered &nbsp;11.6.3 Novartis Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Novartis Main Business Overview &nbsp;11.6.5 Novartis Latest Developments &nbsp;11.7 Pfizer &nbsp;11.7.1 Pfizer Company Information &nbsp;11.7.2 Pfizer Melanoma Drugs Product Offered &nbsp;11.7.3 Pfizer Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Pfizer Main Business Overview &nbsp;11.7.5 Pfizer Latest Developments &nbsp;11.8 Sanofi &nbsp;11.8.1 Sanofi Company Information &nbsp;11.8.2 Sanofi Melanoma Drugs Product Offered &nbsp;11.8.3 Sanofi Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Sanofi Main Business Overview &nbsp;11.8.5 Sanofi Latest Developments &nbsp;11.9 Takeda Pharma &nbsp;11.9.1 Takeda Pharma Company Information &nbsp;11.9.2 Takeda Pharma Melanoma Drugs Product Offered &nbsp;11.9.3 Takeda Pharma Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Takeda Pharma Main Business Overview &nbsp;11.9.5 Takeda Pharma Latest Developments &nbsp;11.10 Teva Pharma &nbsp;11.10.1 Teva Pharma Company Information &nbsp;11.10.2 Teva Pharma Melanoma Drugs Product Offered &nbsp;11.10.3 Teva Pharma Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Teva Pharma Main Business Overview &nbsp;11.10.5 Teva Pharma Latest Developments &nbsp;11.11 Merck Group &nbsp;11.11.1 Merck Group Company Information &nbsp;11.11.2 Merck Group Melanoma Drugs Product Offered &nbsp;11.11.3 Merck Group Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 Merck Group Main Business Overview &nbsp;11.11.5 Merck Group Latest Developments &nbsp;11.12 Shanghai Junshi Biosciences Co.,Ltd &nbsp;11.12.1 Shanghai Junshi Biosciences Co.,Ltd Company Information &nbsp;11.12.2 Shanghai Junshi Biosciences Co.,Ltd Melanoma Drugs Product Offered &nbsp;11.12.3 Shanghai Junshi Biosciences Co.,Ltd Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 Shanghai Junshi Biosciences Co.,Ltd Main Business Overview &nbsp;11.12.5 Shanghai Junshi Biosciences Co.,Ltd Latest Developments &nbsp;11.13 Innovent Biologics &nbsp;11.13.1 Innovent Biologics Company Information &nbsp;11.13.2 Innovent Biologics Melanoma Drugs Product Offered &nbsp;11.13.3 Innovent Biologics Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 Innovent Biologics Main Business Overview &nbsp;11.13.5 Innovent Biologics Latest Developments &nbsp;11.14 Jiangsu Hengrui Medicine Co.,Ltd. &nbsp;11.14.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Information &nbsp;11.14.2 Jiangsu Hengrui Medicine Co.,Ltd. Melanoma Drugs Product Offered &nbsp;11.14.3 Jiangsu Hengrui Medicine Co.,Ltd. Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.14.4 Jiangsu Hengrui Medicine Co.,Ltd. Main Business Overview &nbsp;11.14.5 Jiangsu Hengrui Medicine Co.,Ltd. Latest Developments &nbsp;11.15 BeiGene, Ltd. &nbsp;11.15.1 BeiGene, Ltd. Company Information &nbsp;11.15.2 BeiGene, Ltd. Melanoma Drugs Product Offered &nbsp;11.15.3 BeiGene, Ltd. Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.15.4 BeiGene, Ltd. Main Business Overview &nbsp;11.15.5 BeiGene, Ltd. Latest Developments &nbsp;11.16 Grand Pharmaceutical (China) Co., Ltd &nbsp;11.16.1 Grand Pharmaceutical (China) Co., Ltd Company Information &nbsp;11.16.2 Grand Pharmaceutical (China) Co., Ltd Melanoma Drugs Product Offered &nbsp;11.16.3 Grand Pharmaceutical (China) Co., Ltd Melanoma Drugs Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.16.4 Grand Pharmaceutical (China) Co., Ltd Main Business Overview &nbsp;11.16.5 Grand Pharmaceutical (China) Co., Ltd Latest Developments 12 Research Findings and Conclusion

Report	Global Melanoma Drugs Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI23143

Buyer Information

Order Summary